UBS Group AG Buys 426,409 Shares of Omega Healthcare Investors, Inc. $OHI

UBS Group AG raised its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 30.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,828,655 shares of the real estate investment trust’s stock after buying an additional 426,409 shares during the quarter. UBS Group AG’s holdings in Omega Healthcare Investors were worth $81,083,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in OHI. Mutual Advisors LLC grew its stake in Omega Healthcare Investors by 8.5% during the 3rd quarter. Mutual Advisors LLC now owns 327,383 shares of the real estate investment trust’s stock worth $13,321,000 after buying an additional 25,565 shares during the last quarter. Bank of New York Mellon Corp increased its position in Omega Healthcare Investors by 6.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 3,761,216 shares of the real estate investment trust’s stock valued at $158,799,000 after buying an additional 239,134 shares in the last quarter. CPC Advisors LLC purchased a new stake in Omega Healthcare Investors in the fourth quarter valued at about $3,050,000. Bright Futures Wealth Management LLC. acquired a new stake in Omega Healthcare Investors in the third quarter worth about $458,000. Finally, JPMorgan Chase & Co. boosted its holdings in Omega Healthcare Investors by 77.9% in the third quarter. JPMorgan Chase & Co. now owns 3,417,240 shares of the real estate investment trust’s stock worth $144,278,000 after acquiring an additional 1,496,059 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Stock Up 0.1%

Shares of OHI stock opened at $47.01 on Monday. Omega Healthcare Investors, Inc. has a fifty-two week low of $35.08 and a fifty-two week high of $49.14. The firm has a market capitalization of $14.00 billion, a PE ratio of 22.71, a P/E/G ratio of 2.10 and a beta of 0.59. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.32 and a current ratio of 5.32. The stock’s 50-day simple moving average is $46.38 and its 200-day simple moving average is $44.87.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The firm had revenue of $322.96 million during the quarter, compared to analysts’ expectations of $264.07 million. During the same quarter in the prior year, the company earned $0.75 EPS. Omega Healthcare Investors’s quarterly revenue was up 16.7% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Equities analysts expect that Omega Healthcare Investors, Inc. will post 3.06 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, May 4th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 5.7%. The ex-dividend date of this dividend is Monday, May 4th. Omega Healthcare Investors’s dividend payout ratio is 129.47%.

Analyst Ratings Changes

Several research firms have recently issued reports on OHI. Weiss Ratings upgraded shares of Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a report on Tuesday, April 21st. Bank of America reiterated an “underperform” rating and issued a $46.00 target price (down from $52.00) on shares of Omega Healthcare Investors in a research note on Tuesday, April 14th. Scotiabank boosted their target price on shares of Omega Healthcare Investors from $45.00 to $48.00 and gave the stock a “sector perform” rating in a research report on Monday, March 2nd. Cantor Fitzgerald upped their price target on shares of Omega Healthcare Investors from $50.00 to $52.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Finally, UBS Group reaffirmed a “buy” rating and issued a $52.00 price target on shares of Omega Healthcare Investors in a report on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $48.00.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.